Signaling pathways
-
BA8981 IGF2BP1-IN-1Summary: IGF2BP1-IN-1 is an inhibitor that inhibits downstream signaling. - BA8982 DA-JC4Summary: DA-JC4 is a dual agonist.
- BA8983 PRN694Summary: PRN694 is an irreversible, highly potent and selective, potent covalently bound dual inhibitor of interleukin 2-inducible cell kinase, resting lymphocyte kinase.
- BA8985 GNE-9822Summary: GNE-9822 is an orally effective and selective inhibitor.
- BA8986 GSK-2250665ASummary: GSK-2250665A is a selective inhibitor.
- BA8987 VorolanibSummary: Vorolanib (CM082) is an orally active, potent inhibitor.
- BA8988 TrapidilSummary: Trapidil is a vasodilator.
- BA8990 AnsornitinibSummary: Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2).
- BA8991 NVP-ACC789Summary: An inhibitor.
- BA8992 CT52923Summary: CT52923 is a selective platelet-derived growth factor receptor antagonist with oral activity.